Insider Trading & Ownership of ROBERT HERSHBERG

Location: Boston, MA
Summary: The estimated net worth of ROBERT HERSHBERG is at least $1.21M dollars as of 12 Dec 2025. ROBERT HERSHBERG is the Director of Adaptive Biotechnologies Corp and owns shares of Adaptive Biotechnologies Corp (ADPT) stock worth about $748K. ROBERT HERSHBERG is the Director of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $328K. ROBERT HERSHBERG is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109K. ROBERT HERSHBERG is the Director of NanoString Technologies Inc and owns shares of NS Wind Down Co., Inc. stock worth about $23.5K.
Signature: /s/ Robert Hershberg by Kyle Piskel, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when ROBERT HERSHBERG files a new Insider Trading report.

Ownership of ROBERT HERSHBERG

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ADPT	Adaptive Biotechnologies Corp	Director	$748K	-$770K	-50.7%	10 Dec 2025
RXRX	RECURSION PHARMACEUTICALS, INC.	Director	$328K			18 Jun 2025
FATE	FATE THERAPEUTICS INC	Director	$109K			06 Jun 2023
NSTG	NS Wind Down Co., Inc.	Director	$23.5K			18 Apr 2022
HLVX	HilleVax, Inc.	President and CEO, Director	$0	-$48.7K	-100%	17 Sep 2025
ATAI	ATAI Life Sciences N.V.	Director				05 Nov 2025
SPRY	ARS Pharmaceuticals, Inc.	Director				10 Jun 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.